PLoS neglected tropical diseases · 2011 · 100 citations · 54 references
Life SciencesImmunologyInfectious DiseasesMolecular VirologyVaccinologyVirologyVaccinationVaccine PlatformsVector-based VaccinesViral InfectionsViral VaccinesViral Vector VaccinesCd8 Positive T CellsCytomegalovirus PersistenceCytomegalovirus TransmissionCytomegalovirus VaccinesEbola VaccinesPrimate Infectious DiseasesViral Immunity In WildlifeViral Vector Immunogenicity
BACKGROUND: Human outbreaks of Ebola virus (EBOV) are a serious human health concern in Central Africa. Great apes (gorillas/chimpanzees) are an important source of EBOV transmission to humans due to increased hunting of wildlife including the 'bush-meat' trade. Cytomegalovirus (CMV) is an highly immunogenic virus that has shown recent utility as a vaccine platform. CMV-based vaccines also have the unique potential to re-infect and disseminate through target populations regardless of prior CMV immunity, which may be ideal for achieving high vaccine coverage in inaccessible populations such as great apes. METHODOLOGY/PRINCIPAL FINDINGS: We hypothesize that a vaccine strategy using CMV-based vectors expressing EBOV antigens may be ideally suited for use in inaccessible wildlife populations. To establish a 'proof-of-concept' for CMV-based vaccines against EBOV, we constructed a mouse CMV (MCMV) vector expressing a CD8+ T cell epitope from the nucleoprotein (NP) of Zaire ebolavirus (ZEBOV) (MCMV/ZEBOV-NP(CTL)). MCMV/ZEBOV-NP(CTL) induced high levels of long-lasting (>8 months) CD8+ T cells against ZEBOV NP in mice. Importantly, all vaccinated animals were protected against lethal ZEBOV challenge. Low levels of anti-ZEBOV antibodies were only sporadically detected in vaccinated animals prior to ZEBOV challenge suggesting a role, at least in part, for T cells in protection. CONCLUSIONS/SIGNIFICANCE: This study demonstrates the ability of a CMV-based vaccine approach to protect against an highly virulent human pathogen, and supports the potential for 'disseminating' CMV-based EBOV vaccines to prevent EBOV transmission in wildlife populations.
54
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations
Fruit bats as reservoirs of Ebola virus
Eric M. Leroy, Brice Kumulungui, Xavier Pourrut et al. · Nature · 2005 · 1.6K citations · Full text
Andrew Sylwester, Bridget L. Mitchell, John B. Edgar et al. · The Journal of Experimental Medicine · 2005 · 1.3K citations · Full text
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Hisashi Arase, Edward S. Mocarski, Ann E. Campbell et al. · Science · 2002 · 1.2K citations
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen, Julia C. Ford, Matthew S. Lewis et al. · Nature · 2011 · 993 citations · Full text